Clinical Trials

Novartis to Highlight Updated Data from the P-III (NATALEE) Study of Kisqali (Ribociclib) for Treating Early Breast Cancer (EBC) at ESMO 2024

Novartis to Highlight Updated Data from the P-III (NATALEE) Study of Kisqali (Ribociclib) for Treating Early Breast Cancer (EBC) a...

Shots: Novartis will highlight 4yrs. post-hoc analysis from P-III (NATALEE) study...

Neurocrine Biosciences Provides P-II (ERUDITE) Study Updates of Luvadaxistat for Cognitive Impairment Associated with Schizophrenia

Neurocrine Biosciences Provides P-II (ERUDITE) Study Updates of Luvadaxistat for Cognitive Impairment Associated with Schizophreni...

Shots: Neurocrine has provided updates on the P-II (ERUDITE) trial assessing the s...

Bayer Reports the P-III (OASIS 3) Trial Data of Elinzanetant to Treat Vasomotor Symptoms in Postmenopausal Women

Bayer Reports the P-III (OASIS 3) Trial Data of Elinzanetant to Treat Vasomotor Symptoms in Postmenopausal Women

Shots: Bayer plans to highlight full results from the P-III (

Sanofi Reports the P-III (LIBERTY-CUPID Study C) Trial Data of Dupixent to Treat Chronic Spontaneous Urticaria (CSU)

Sanofi Reports the P-III (LIBERTY-CUPID Study C) Trial Data of Dupixent to Treat Chronic Spontaneous Urticaria (CSU)

Shots: The P-III (LIBERTY-CUPID Study C) trial assessed Dupixent + SoC (H1 antihis...

Image